跳至主要内容
临床试验/CTRI/2021/10/037162
CTRI/2021/10/037162尚未招募不适用

A Nidanatmaka (Epidemiological) Study on Raktagata Vata (Hypertension) and An Upashayatmaka (Therapeutic) Study to Evaluate The Efficacy of Aswagandha Churna.

Government Ayurvedic College and Hospital Patna1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年10月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in sign and symptom of Raktagata vata

研究概览

简要总结

Hypertension is an important worldwide public health challenge and remains a cause of morbidity and mortality worldwide.In ayurveda the symptoms of raktagata vata very much resembles with hypertension.As we know the description about raktagata vata and hypertension is avilable in ancient literature but the correlative interpretation between Raktagata vata and Hypertension has not been clear.So, study efforts are done to understand the concept of Raktagata vata in terms of Nidan Panchak and also to collect the various preventive measures for hypertension in Ayurveda such as life style management and upashyatmaka role of Ashwagandha churna on Hypertension.Potent anti- stress and anti-anxiety effect helps to reduce Hypertension.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient having classical symptoms of Raktagata Vata given in samhitas will be taken.

排除标准

  • Pregnant women and lactating mother.
  • Patient suffering from genetical and congenital disease.
  • Patient having BP more than 200/100mmHg are excluded.
  • Patient having any complication like Diabetes and cancer.

结局指标

主要结局

Improvement in sign and symptom of Raktagata vata

时间窗: 2 months

次要结局

  • Improvement in Raktagata vata(Improvement in sign and symptoms of Raktagata vata)

研究者

发起方
Government Ayurvedic College and Hospital Patna
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验